Navigation Links
TGen Drug Development partners with Imaging Endpoints for comprehensive clinical trial services
Date:6/9/2011

SCOTTSDALE, Ariz. June 9, 2011 TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the companies announced today.

"The highest quality medical imaging provided by Imaging Endpoints is one more weapon in TD2's arsenal," said Dr. Stephen Gately, President of TD2, which assists drug developers in navigating the regulatory maze involved in the successful completion of clinical trials and bringing new therapeutics to market. "Our relationship is meant to help combine the best available technologies."

Imaging Endpoints will assist TD2 in the design and implementation of medical imaging analyses. Imaging Endpoints' expertise in anatomic and functional imaging will allow drug developers to best incorporate imaging into their clinical trials: probing molecular drug targets, assessing biologic responses and evaluating drug effectiveness.

"We hope that, through our new relationship with TD2, we will be able to assist oncology drug developers to maximize their return on investment in medical imaging during the course of their early-phase clinical trials," said Ron Korn, Medical Director of Imaging Endpoints. "Significant resources and time can be saved through wise and appropriate implementation of medical imaging."

The rapid completion of often time-consuming and costly clinical trials is needed to speed new treatments to the patients who need them, Dr. Gately said.

Scottsdale Mayor Jim Lane hailed the announcement by TD2 and Imaging Endpoints: "The partnership announced today between TD2 and Imaging Endpoints represents the merging of talents between two premier Scottsdale companies, and helps cement TD2 as a cornerstone of Scottsdale's growing biomedical industry."

Imaging holds the potential to predict outcomes, shorten the time needed to evaluate if a drug is hitting its target, and do so with relatively low risk to patients. By using specific imaging techniques, researchers can assess if new drug compounds are effective in such areas as anti-proliferation, metabolism and hypoxia.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Study finds widespread stream biodiversity declines at low levels of urban development
2. Development of a FRET sensor for real-time imaging of intracellular redox dynamics
3. Developmental disease is recreated in an adult model
4. Ulcer bacteria may contribute to development of Parkinsons disease
5. A study will enable the survival and growth of the 3 development phases of the European eel
6. Building brains: An introduction to neural development
7. Gene variant linked with development of COPD in men
8. Scientists find new class of compounds with great potential for research and drug development
9. New organic catalyst should enhance drug research and development
10. Brain development goes off track as vulnerable individuals develop schizophrenia
11. Study: Pace of brain development still strong in late teens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... (PRWEB) , ... March 28, ... ... announced its partnership with the American Association for the Advancement of Science ... Science. Through this partnership, ReadCube will enhance its high-impact scholarly collection across ...
(Date:3/28/2017)... ... March 28, 2017 , ... Franz Inc ., the leading supplier of ... been named a ‘Champion’ by Bloor Research in its recent Graph Database Market ... class, and, thanks to Gruff, it was rated as the easiest product to use.” ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of the Modular Building Institute (MBI), an international modular trade organization, were awarded ... modular category for the Pagliuca Life Lab at Harvard University. The awards were ...
(Date:3/28/2017)... 28, 2017 Volition America, Inc., a wholly-owned U.S. ... engagement of Deborah Vollmer Dahlke , DrPH, CEO and ... Vollmer Dahlke,s role will be to assist the ... State of Texas and elsewhere in ... has significant experience over the past six years, helping ...
Breaking Biology Technology: